GE HealthCare Files 8-K: Corporate Updates

TL;DR

GE HealthCare filed an 8-K on 8/15 for corporate updates, check their Chicago HQ address and contact info.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on August 15, 2024, reporting other events and financial statements/exhibits. The filing confirms their principal executive offices are located at 500 West Monroe Street, Chicago, IL 60661, and their telephone number is (833) 735-1139. The report covers events up to August 14, 2024.

Why It Matters

This 8-K filing provides official updates on GE HealthCare's corporate structure and reporting, which is important for investors tracking the company's regulatory compliance and operational details.

Risk Assessment

Risk Level: low — This filing is routine and primarily informational, containing corporate details rather than significant financial or operational changes.

Key Players & Entities

• GE HealthCare Technologies Inc. (company) — Registrant
• August 14, 2024 (date) — Earliest event reported
• August 15, 2024 (date) — Date of report
• 500 West Monroe Street, Chicago, IL 60661 (location) — Principal executive offices
• (833) 735-1139 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001193125-24-201356.txt : 20240815 0001193125-24-201356.hdr.sgml : 20240815 20240815163753 ACCESSION NUMBER: 0001193125-24-201356 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240814 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240815 DATE AS OF CHANGE: 20240815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241212991 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d868737d8k.htm 8-K 8-K false 0001932393 0001932393 2024-08-14 2024-08-14     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2024     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 500 W. Monroe Street , Chicago , IL     60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139 (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On August 14, 2024, GE HealthCare Technologies Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.800% Notes due August 14, 2029 (the “Notes”) pursuant to its effective shelf registration statement on Form S-3 (File No. 333-280584). The Company will pay interest on the Notes on February 14 and August 14 of each year, beginning on February 14, 2025. The Notes will mature on August 14, 2029. The Notes